Charles River Laboratories International Inc
NYSE:CRL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Charles River Laboratories International Inc
NYSE:CRL
|
US |
|
FRMO Corp
OTC:FRMO
|
US |
Wall Street
Price Targets
CRL Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for
CRL
is 206.27 USD
with a low forecast of 158.01 USD and a high forecast of 278.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRL's stock price target?
Price Target
206.27
USD
According to Wall Street analysts, the average 1-year price target for
CRL
is 206.27 USD
with a low forecast of 158.01 USD and a high forecast of 278.25 USD.
What is Charles River Laboratories International Inc's Revenue forecast?
Projected CAGR
3%
For the last 14 years the
compound annual growth rate for
Charles River Laboratories International Inc's revenue is
9%.
The projected
CAGR
for the next 3 years is
3%.
What is Charles River Laboratories International Inc's Operating Income forecast?
Projected CAGR
20%
For the last 14 years the
compound annual growth rate for
Charles River Laboratories International Inc's operating income is
7%.
The projected
CAGR
for the next 3 years is
20%.
